Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Price to FCF (2022 - 2023)

Updated

Inhibitor Therapeutics' (INTI) Price to FCF was 0.87 for Q3 2023, up 31.5% from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Price to FCF (2022 - 2023) Analysis & Trends

For FY2022, Price to FCF at Inhibitor Therapeutics was 3.12.

  • Five-year quarterly Price to FCF spans a low of 0.66 in Q2 2023 and a high of 3.12 in Q4 2022.
  • Per Business Quant data, the three quarters before Q3 2023 came in at 0.66 (Q2 2023), 0.93 (Q1 2023) and 3.12 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 0.87
Jun 30, 2023 0.66
Mar 31, 2023 0.93
Dec 31, 2022 3.12
API Access

Inhibitor Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=INTI&period=max&api_key=YOUR_API_KEY